SANOFI-AVENTIS (EPA:SAN) Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The NEJM
Transparency directive : regulatory news
18/10/2023 10:45